Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

News Articles from Monday 1st of June 2009

17:29: FDA Commissioner Hamburg to Deliver Keynote at RAPS Conference

http://www.bioportfolio.com/news/FDA_Commissioner_Hamburg_to_Deliver_Keynote_at.html

17:15: Go Red For Women(R) Launches 12-Week Program to Improve Heart Health and Save Lives

http://www.bioportfolio.com/news/Go_Red_For_Women%28R%29_Launches_12-Week_Program_to.html

17:13: St. Louis Metro Area Optometrists Partner With Sen. Bond; U.S. House Leaders in Improving Infant Eye and Vision Care

http://www.bioportfolio.com/news/St._Louis_Metro_Area_Optometrists_Partner_With.html

17:12: Study to Investigate AHCC and the Swine Flu Virus

http://www.bioportfolio.com/news/Study_to_Investigate_AHCC_and_the_Swine_Flu.html

16:36: New Brunswick - St. Peter's Hospital Unveils an Addition to Its Cancer Treatment Program.

http://www.bioportfolio.com/news/New_Brunswick_-_St._Peter%26apos%3Bs_Hospital_Unveils.html

16:35: Streamwood Hospital Opens New Children's Center to Meet Vital Community Need

http://www.bioportfolio.com/news/Streamwood_Hospital_Opens_New_Children%26apos%3Bs.html

16:30: PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference

http://www.bioportfolio.com/news/PROTECT-1_Phase_II%2FIII_Induction-Stage_Results.html

16:15: Texan First to Receive CIMZIA(R) (certolizumab pegol) for Moderately to Severely Active Rheumatoid Arthritis

http://www.bioportfolio.com/news/Texan_First_to_Receive_CIMZIA%28R%29_%28certolizumab.html

16:02: Immucor Announces Fiscal Year 2010 Guidance

http://www.bioportfolio.com/news/Immucor_Announces_Fiscal_Year_2010.html

16:01: Chindex International, Inc. to Report Fourth Quarter and Full Year Fiscal 2009 Financial Results

http://www.bioportfolio.com/news/Chindex_International%2C_Inc._to_Report_Fourth.html

16:00: Eileen McPartland Joins Allscripts as Chief Operating Officer

http://www.bioportfolio.com/news/Eileen_McPartland_Joins_Allscripts_as_Chief.html

16:00: Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Inspiring Triathlete Visits Honolulu Tuesday, June 2, 2009, 10:00 am - 2:00 pm

http://www.bioportfolio.com/news/Ironman_Competitor_with_Diabetes_Encourages.html

15:45: Cedars-Sinai Medical Center's 24th Annual Sports Spectacular Set for Sunday, June 7, 2009

http://www.bioportfolio.com/news/Cedars-Sinai_Medical_Center%26apos%3Bs_24th_Annual.html

15:30: FINAL INCHES has Your 'Custom' Solution to Spring Into Summer With a New Body!

http://www.bioportfolio.com/news/FINAL_INCHES_has_Your_%26apos%3BCustom%26apos%3B_Solution.html

15:18: PROXY Governance and Glass Lewis Recommend That Stockholders Vote the White Proxy Card in Support of All Providence Nominees

http://www.bioportfolio.com/news/PROXY_Governance_and_Glass_Lewis_Recommend_That.html

15:16: AARP to Host Cross-Generational 'Life Festival' in Chicago, June 5-6

http://www.bioportfolio.com/news/AARP_to_Host_Cross-Generational_%26apos%3BLife.html

15:15: Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain

http://www.bioportfolio.com/news/Horizon_Therapeutics%26apos%3B_HZT-501_Significantly.html

15:00: New Study Documents High Prevalence of Serious Mental Illnesses Among Nation's Jail Populations

http://www.bioportfolio.com/news/New_Study_Documents_High_Prevalence_of_Serious.html

15:00: JOIN Funding Collaborative Connects Philadelphia Workers to Living-Wage Green, Healthcare Jobs

http://www.bioportfolio.com/news/JOIN_Funding_Collaborative_Connects_Philadelphia.html

14:59: Mylan's Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Companies and Tactics That Delay Market Entry of High Quality, Affordable Generic Drugs

http://www.bioportfolio.com/news/Mylan%26apos%3Bs_Chief_Operating_Officer_Heather.html

14:55: BASF Sues DuPont for Patent Infringement

http://www.bioportfolio.com/news/BASF_Sues_DuPont_for_Patent.html

14:52: Tim McGraw and Faith Hill Join Senior Military for Country United: Advancing Medicine From the Frontlines to the Homefront

http://www.bioportfolio.com/news/Tim_McGraw_and_Faith_Hill_Join_Senior_Military.html

14:44: AMA Outlines Initiatives to White House to Help Slow Increases In Health Spending

http://www.bioportfolio.com/news/AMA_Outlines_Initiatives_to_White_House_to_Help.html

14:39: CQ HealthBeat Policy Preview Conference -- June 3, 2009

http://www.bioportfolio.com/news/CQ_HealthBeat_Policy_Preview_Conference_--_June.html

14:30: New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography

http://www.bioportfolio.com/news/New_Market_Research_Study_Shows_Lung_Cancer.html

14:25: MHPA, Leading Association Representing Medicaid Health Plans, Issues Statement on Proposed California SCHIP Elimination

http://www.bioportfolio.com/news/MHPA%2C_Leading_Association_Representing_Medicaid.html

14:19: Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service

http://www.bioportfolio.com/news/Quest_Diagnostics_Introduces_First_Comprehensive.html

14:15: IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

http://www.bioportfolio.com/news/IMPACT_Study_Showed_Longer_Valcyte%28R%29.html

14:08: Ingenious Med Experiences Impressive Growth in First Quarter 2009

http://www.bioportfolio.com/news/Ingenious_Med_Experiences_Impressive_Growth_in.html

14:00: Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

http://www.bioportfolio.com/news/Pixantrone_Significantly_Increases_Complete.html

13:53: 'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Montana

http://www.bioportfolio.com/news/%26apos%3BViewers_Beware%26apos%3B_Report_by_Watchdog.html

13:52: "Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in South Dakota

http://www.bioportfolio.com/news/%26quot%3BViewers_Beware%26quot%3B_Report_by_Watchdog.html

13:52: 'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Virginia

http://www.bioportfolio.com/news/%26apos%3BViewers_Beware%26apos%3B_Report_by_Watchdog.html

13:45: 'Viewers Beware' Report By Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running In Nebraska

http://www.bioportfolio.com/news/%26apos%3BViewers_Beware%26apos%3B_Report_By_Watchdog.html

13:44: "Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Indiana

http://www.bioportfolio.com/news/%26quot%3BViewers_Beware%26quot%3B_Report_by_Watchdog.html

13:40: Assay Designs(TM), Inc. Announces Release of First Available Product for Multiplex Analysis of Heat Shock Proteins

http://www.bioportfolio.com/news/Assay_Designs%28TM%29%2C_Inc._Announces_Release_of.html

13:40: Nuvilex Launches Video Marketing Campaign

http://www.bioportfolio.com/news/Nuvilex_Launches_Video_Marketing.html

13:33: 'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Louisiana

http://www.bioportfolio.com/news/%26apos%3BViewers_Beware%26apos%3B_Report_by_Watchdog.html

13:30: Microsoft Signs Agreement With Merck & Co. Inc. to Acquire Assets of Rosetta Biosoftware, Strengthening Position in Life Sciences Industry

http://www.bioportfolio.com/news/Microsoft_Signs_Agreement_With_Merck_%26amp%3B_Co..html

13:29: 'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Arkansas

http://www.bioportfolio.com/news/%26apos%3BViewers_Beware%26apos%3B_Report_by_Watchdog.html

13:28: 'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Alaska

http://www.bioportfolio.com/news/%26apos%3BViewers_Beware%26apos%3B_Report_by_Watchdog.html

13:15: Progressive Groups to Spend More Than $82 Million to Ensure Real Health Care Reform Passes This Year

http://www.bioportfolio.com/news/Progressive_Groups_to_Spend_More_Than_%2482_Million.html

13:13: ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis

http://www.bioportfolio.com/news/ISTA_Pharmaceuticals_Announces_FDA_Advisory.html

13:08: Sacred Heart Hospital Starts to Expose Students to Stroke Awareness at an Early Age

http://www.bioportfolio.com/news/Sacred_Heart_Hospital_Starts_to_Expose_Students.html

13:00: Michael J. Fox Foundation Announces Launch of PD Online Research

http://www.bioportfolio.com/news/Michael_J._Fox_Foundation_Announces_Launch_of_PD.html

13:00: Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting

http://www.bioportfolio.com/news/Data_From_Clinical_Study_of_bioTheranostics.html

13:00: Minnesota Health Plans Select IGI and ORBIT(R) to Power First State-Mandated Shift to Standardized, Electronic Data Exchange between Plans and Providers

http://www.bioportfolio.com/news/Minnesota_Health_Plans_Select_IGI_and_ORBIT%28R%29_to.html

13:00: June 18 Conference Features Legal, Medical & Scientific Presentations

http://www.bioportfolio.com/news/June_18_Conference_Features_Legal%2C_Medical_%26amp%3B.html

12:58: Niutang Sucralose Patent Litigation Successfully Concluded

http://www.bioportfolio.com/news/Niutang_Sucralose_Patent_Litigation_Successfully.html

12:57: 'Viewers Beware' Report By Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running In Eight States

http://www.bioportfolio.com/news/%26apos%3BViewers_Beware%26apos%3B_Report_By_Watchdog.html

12:46: Biotech Shows Glimmer of an Upward Trend

http://www.bioportfolio.com/news/Biotech_Shows_Glimmer_of_an_Upward.html

12:36: Sparta Systems Launches Hong Kong Operations to Drive Enterprise Quality and Compliance in Asia-Pacific Region

http://www.bioportfolio.com/news/Sparta_Systems_Launches_Hong_Kong_Operations_to.html

12:33: AT&T Shares 2009 NCAA Women's College World Series With American Cancer Society and Boys & Girls Club

http://www.bioportfolio.com/news/AT%26amp%3BT_Shares_2009_NCAA_Women%26apos%3Bs_College.html

12:32: Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference, June 2-3, 2009

http://www.bioportfolio.com/news/Senators_Arlen_Specter_and_John_Cornyn_Will.html

12:30: Bringing Uninsured and Underinsured Issues Into the Spotlight in the Louisiana State Legislature

http://www.bioportfolio.com/news/Bringing_Uninsured_and_Underinsured_Issues_Into.html

12:05: Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization

http://www.bioportfolio.com/news/Exclusive_Marketplace_for_Nursing_Professionals.html

12:00: Foamtec International Takes the Strain Out of Cleanroom Mopping

http://www.bioportfolio.com/news/Foamtec_International_Takes_the_Strain_Out_of.html

12:00: Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis

http://www.bioportfolio.com/news/Raptor_Pharmaceuticals_Doses_First_Patient_in.html

11:58: Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region

http://www.bioportfolio.com/news/Roshan_Announces_Expansion_of_Afghanistan%26apos%3Bs.html

11:58: Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants

http://www.bioportfolio.com/news/Findings_in_Epilepsy_Gene_in_Animals_May_Guide.html

11:28: AgeEsteem(R) Launches New Web Site, Blog, and 'How To' Book

http://www.bioportfolio.com/news/AgeEsteem%28R%29_Launches_New_Web_Site%2C_Blog%2C_and.html

11:16: When Lawn Mowers Attack: National Medical Societies Offer Tips to Prevent Injuries; Children Often Victims

http://www.bioportfolio.com/news/When_Lawn_Mowers_Attack%3A_National_Medical.html

11:09: Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator

http://www.bioportfolio.com/news/Availity_Teams_with_Thomson_Reuters_to_Integrate.html

11:09: Valeritas Announces Appointment of New CEO

http://www.bioportfolio.com/news/Valeritas_Announces_Appointment_of_New.html

11:01: Adult Glioblastoma: Best Approaches to a Challenging Diagnosis

http://www.bioportfolio.com/news/Adult_Glioblastoma%3A_Best_Approaches_to_a.html

11:00: Majority of British Women Would Choose a Double Chin Over the Dreaded 'LBB'

http://www.bioportfolio.com/news/Majority_of_British_Women_Would_Choose_a_Double.html

11:00: Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America

http://www.bioportfolio.com/news/Physicians_Join_With_National_Healthcare_Leaders.html

11:00: Tom Lescault, President of SCAN Health Plan Arizona, Appointed to Parkinson Network of Arizona Board of Directors

http://www.bioportfolio.com/news/Tom_Lescault%2C_President_of_SCAN_Health_Plan.html

10:50: Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA)

http://www.bioportfolio.com/news/Edward_Diehl_Receives_Outstanding_Achievement.html

10:42: John Hancock Launches New Retirement Income Solution

http://www.bioportfolio.com/news/John_Hancock_Launches_New_Retirement_Income.html

10:37: Seabrook House, Inc. Successful in Recession Due to the Acceptance of Most Insurances; Expands With New Hires Due to the Growth of the Company

http://www.bioportfolio.com/news/Seabrook_House%2C_Inc._Successful_in_Recession_Due.html

10:20: Prominent Farmington Hills Plastic Surgeon Suggests Methods to Repair Skin Damaged by Sun Exposure

http://www.bioportfolio.com/news/Prominent_Farmington_Hills_Plastic_Surgeon.html

10:15: Dr. Tiller's Death and Abortion: Press Conference With Randall Terry at National Press Club at 1:00 P.M., Monday, June 1st

http://www.bioportfolio.com/news/Dr._Tiller%26apos%3Bs_Death_and_Abortion%3A_Press.html

10:08: Abbott to Present at Goldman Sachs Global Healthcare Conference

http://www.bioportfolio.com/news/Abbott_to_Present_at_Goldman_Sachs_Global.html

10:05: Record 73.4 Million Pounds Collected in Letter Carriers' National Food Drive

http://www.bioportfolio.com/news/Record_73.4_Million_Pounds_Collected_in_Letter.html

10:04: Kendle Expands Asia/Pacific Operations with Opening of Offices in Kuala Lumpur, Bangkok and Manila

http://www.bioportfolio.com/news/Kendle_Expands_Asia%2FPacific_Operations_with.html

10:00: Explorer's Bounty Coffees and Chocolates Helping Individuals Reverse the Aging Process

http://www.bioportfolio.com/news/Explorer%26apos%3Bs_Bounty_Coffees_and_Chocolates.html

10:00: Video: truth(R) Asks: 'Do You Have What it Takes?'

http://www.bioportfolio.com/news/Video%3A_truth%28R%29_Asks%3A_%26apos%3BDo_You_Have_What_it.html

10:00: Call for Nominations for the 2009 C.A.R.E. Pharmacy Award

http://www.bioportfolio.com/news/Call_for_Nominations_for_the_2009_C.A.R.E..html

09:48: Retired or Laid Off? Why Not Operate Your Own Business in 2009! Invest in YOU. Become an Entrepreneur!

http://www.bioportfolio.com/news/Retired_or_Laid_Off%3F__Why_Not_Operate_Your_Own.html

09:45: S.C. BlueCross Makes Coverage Available for Thousands of South Carolina Graduates Lacking Health Insurance

http://www.bioportfolio.com/news/S.C._BlueCross_Makes_Coverage_Available_for.html

09:26: State-of-the-Art Address Today: Transplantation Experts to Present Vital Data

http://www.bioportfolio.com/news/State-of-the-Art_Address_Today%3A_Transplantation.html

09:20: National Museum of Dentistry Opens New Smile Experience, Exhibition Recognizes Dr. Irwin Smigel as Father of Aesthetic Dentistry

http://www.bioportfolio.com/news/National_Museum_of_Dentistry_Opens_New_Smile.html

09:19: HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

http://www.bioportfolio.com/news/HHS_Awards_MedImmune_Contract_to_Manufacture_Live.html

09:15: drugstore.com, inc. to Present at Upcoming Financial Conferences

http://www.bioportfolio.com/news/drugstore.com%2C_inc._to_Present_at_Upcoming.html

09:08: Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

http://www.bioportfolio.com/news/Cimzia%28R%29_%28certolizumab_pegol%29_Provides_Long-Term.html

09:07: UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows

http://www.bioportfolio.com/news/UCB_and_Crohn%26apos%3Bs_Disease_Working_Group_Award.html

09:07: New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy

http://www.bioportfolio.com/news/New_Data_Support_Use_of_Simple_Test_to_Predict.html

09:06: BayCare Named CIO 100 Award Winner by CIO Magazine

http://www.bioportfolio.com/news/BayCare_Named_CIO_100_Award_Winner_by_CIO.html

09:06: Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients

http://www.bioportfolio.com/news/Laboratory_Test_May_Predict_Effectiveness_of.html

09:02: PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests

http://www.bioportfolio.com/news/PLUS_Diagnostics_First_National_Laboratory_to.html

09:01: Chocolate Milk's 'Natural' Muscle Recovery Benefits Match or May Even Surpass a Specially Designed Carbohydrate Sports Drink

http://www.bioportfolio.com/news/Chocolate_Milk%26apos%3Bs_%26apos%3BNatural%26apos%3B_Muscle.html

09:00: Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting

http://www.bioportfolio.com/news/Peregrine_Pharmaceuticals_Presents_Promising_Data.html

09:00: Milk Helps Refuel and Pay the Way to College for 25 Teens

http://www.bioportfolio.com/news/Milk_Helps_Refuel_and_Pay_the_Way_to_College_for.html

09:00: SafeLiftingPortal.com Launches New Resource Focused on Home Care Patient Safety and Injury Prevention

http://www.bioportfolio.com/news/SafeLiftingPortal.com_Launches_New_Resource.html

09:00: Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan

http://www.bioportfolio.com/news/Cyberonics_Announces_Exclusive_Distribution.html

09:00: HealthEdge(R) Announces Support for ICD-10 in the Award-Winning HealthRules(R) Product Suite

http://www.bioportfolio.com/news/HealthEdge%28R%29_Announces_Support_for_ICD-10_in_the.html

09:00: Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors

http://www.bioportfolio.com/news/Mersana_Reports_Preliminary_Phase_1_Results_of.html

09:00: FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

http://www.bioportfolio.com/news/FDA_Approves_Labeling_Change_for_VYVANSE%28R%29.html

09:00: Life Strategy Firm Launches Proprietary Life Design Program and 'Examined Life Seminar Series' to Meet Growing Demand for Life Transition Guidance

http://www.bioportfolio.com/news/Life_Strategy_Firm_Launches_Proprietary_Life.html

09:00: Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System

http://www.bioportfolio.com/news/Endologix_Announces_Full_Commercial_Launch_of.html

09:00: Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

http://www.bioportfolio.com/news/Access_Pharmaceuticals_Provides_Update_on.html

09:00: Microsoft to Showcase Innovative Solutions for Health Plans at AHIP Institute

http://www.bioportfolio.com/news/Microsoft_to_Showcase_Innovative_Solutions_for.html

09:00: ID Experts Inputs to FTC and HHS Health Breach Notification Rules

http://www.bioportfolio.com/news/ID_Experts_Inputs_to_FTC_and_HHS_Health_Breach.html

09:00: Sunesis Pharmaceuticals Presents Voreloxin Clinical Data at the American Society of Clinical Oncology 2009 Annual Meeting

http://www.bioportfolio.com/news/Sunesis_Pharmaceuticals_Presents_Voreloxin.html

09:00: AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use

http://www.bioportfolio.com/news/AGA_Institute_and_Horizon_Therapeutics_Launch.html

08:57: Mott's(R) and Susan G. Komen for the Cure(R) Go 'Pink to the Core(TM)'

http://www.bioportfolio.com/news/Mott%26apos%3Bs%28R%29_and_Susan_G._Komen_for_the_Cure%28R%29.html

08:52: Champions Biotechnology, Inc. Launches PersonalizedCancerTreatment.com

http://www.bioportfolio.com/news/Champions_Biotechnology%2C_Inc._Launches.html

08:41: BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research

http://www.bioportfolio.com/news/BD_Biosciences_Launches_New_Cell_Analyzer_for.html

08:38: NxStage Extends Supply Agreement with B. Braun Medical Inc. to Include Streamline(R) Technology

http://www.bioportfolio.com/news/NxStage_Extends_Supply_Agreement_with_B._Braun.html

08:35: AEterna Zentaris Partner Keryx Reports Positive Phase 2 Data for Perifosine (KRX-0401) in Colon and Kidney Cancer at ASCO Meeting

http://www.bioportfolio.com/news/AEterna_Zentaris_Partner_Keryx_Reports_Positive.html

08:30: Glass Lewis Recommends That Stockholders Vote the WHITE Proxy Card in Support of All Providence Nominees

http://www.bioportfolio.com/news/Glass_Lewis_Recommends_That_Stockholders_Vote_the.html

08:30: Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2009

http://www.bioportfolio.com/news/Cantel_Medical_Corp._To_Hold_Conference_Call_To.html

08:30: Francisco Ascencion Named President, Bausch & Lomb Japan

http://www.bioportfolio.com/news/Francisco_Ascencion_Named_President%2C_Bausch_%26amp%3B.html

08:30: IPC The Hospitalist Company, Inc. to Present at William Blair's 29th Annual Growth Stock Conference

http://www.bioportfolio.com/news/IPC_The_Hospitalist_Company%2C_Inc._to_Present_at.html

08:30: Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer

http://www.bioportfolio.com/news/Keryx_Biopharmaceuticals_Announces_Positive_Data.html

08:30: Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

http://www.bioportfolio.com/news/Neurobiological_Technologies%26apos%3B_Partner%2C.html

08:30: Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting

http://www.bioportfolio.com/news/Proteolix_Presents_Positive_Clinical_Data_for.html

08:25: Leading Plastic Surgeons Makhlouf and Parungao Join ChicagoAesthetic.com

http://www.bioportfolio.com/news/Leading_Plastic_Surgeons_Makhlouf_and_Parungao.html

08:15: Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study

http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Reports_Encouraging_Final.html

08:15: Unprecedented Merger Occurs in Retained Physician Search Industry

http://www.bioportfolio.com/news/Unprecedented_Merger_Occurs_in_Retained_Physician.html

08:10: Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic

http://www.bioportfolio.com/news/Veran_Medical_Technologies_Announces_Intellectual.html

08:10: For Patients With Irritable Bowel Syndrome (IBS), iPhone to the Rescue

http://www.bioportfolio.com/news/For_Patients_With_Irritable_Bowel_Syndrome_%28IBS%29%2C.html

08:09: NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS

http://www.bioportfolio.com/news/NIMOTUZUMAB_DEMONSTRATES_EFFICACY_IN_RANDOMIZED.html

08:07: Millennium Research Group's New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool

http://www.bioportfolio.com/news/Millennium_Research_Group%26apos%3Bs_New_Perception.html

08:00: Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program

http://www.bioportfolio.com/news/Ryder_System%2C_Inc._Joins_the_American_Red_Cross.html

08:00: Randomized Controlled Trial of Radioactive Resin Microspheres Demonstrates Significant Delay in Progression of Disease in Patients With Colorectal Cancer Liver Metastases who Have Exhausted Chemotherapy

http://www.bioportfolio.com/news/Randomized_Controlled_Trial_of_Radioactive_Resin.html

08:00: Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week

http://www.bioportfolio.com/news/Shire_Presented_Results_of_a_New_Database.html

08:00: Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative

http://www.bioportfolio.com/news/Researchers_at_the_Karmanos_Cancer_Institute_in.html

08:00: Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal

http://www.bioportfolio.com/news/Valeant_Grants_Schering-Plough_Exclusive_Option.html

08:00: Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO

http://www.bioportfolio.com/news/Isis_Highlights_New_Clinical_Data_on_Anti-Cancer.html

08:00: Amgen's Denosumab and Eli Lilly's Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018

http://www.bioportfolio.com/news/Amgen%26apos%3Bs_Denosumab_and_Eli_Lilly%26apos%3Bs.html

08:00: While Pulmonologists and Patients Perceive Spiriva Favorably, PCP Perception is Lower Than Other Leading COPD Brands

http://www.bioportfolio.com/news/While_Pulmonologists_and_Patients_Perceive.html

08:00: Video: Provectus Reports Encouraging Clinical Data at ASCO on Treatment of Metastatic Melanoma With PV-10

http://www.bioportfolio.com/news/Video%3A__Provectus_Reports_Encouraging_Clinical.html

08:00: Vion Pharmaceuticals Presents Data on Onrigin(TM) Elderly AML Trials at the ASCO(R) Annual Meeting

http://www.bioportfolio.com/news/Vion_Pharmaceuticals_Presents_Data_on_Onrigin%28TM%29.html

08:00: PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations

http://www.bioportfolio.com/news/PTC_Therapeutics_Appoints_Clare_Kennedy_as_Vice.html

08:00: Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

http://www.bioportfolio.com/news/Ascenta_Therapeutics_Announces_Presentation_of.html

08:00: FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy

http://www.bioportfolio.com/news/FDA_Approves_Lamictal%28R%29XR%28TM%29%3B_An.html

08:00: Apieron Secures Series D Commitments

http://www.bioportfolio.com/news/Apieron_Secures_Series_D.html

08:00: Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer

http://www.bioportfolio.com/news/Bayer_and_Onyx_Initiate_Phase_3_Trial_of_Nexavar.html

08:00: MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage

http://www.bioportfolio.com/news/MDS_Nordion_Urges_Government_of_Canada_to.html

07:35: Practice-Reps Brings Sales and Marketing to the Business of Medical Practice Management

http://www.bioportfolio.com/news/Practice-Reps_Brings_Sales_and_Marketing_to_the.html

07:32: Neovasc Inc. Reports First Quarter 2009 Financial Results

http://www.bioportfolio.com/news/Neovasc_Inc._Reports_First_Quarter_2009_Financial.html

07:30: Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers

http://www.bioportfolio.com/news/Rigel%26apos%3Bs_R788_Evaluated_in_Phase_2_Trial_in.html

07:30: Pharmacyclics Files Registration Statement for Rights Offering

http://www.bioportfolio.com/news/Pharmacyclics_Files_Registration_Statement_for.html

07:30: Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting

http://www.bioportfolio.com/news/Oncolytics_Biotech%28R%29_Inc._Collaborators_Present.html

07:25: RecoveryPlanner and RiskWatch Partner to Deliver an Integrated Business Continuity-Risk Management Software Solution

http://www.bioportfolio.com/news/RecoveryPlanner_and_RiskWatch_Partner_to_Deliver.html

07:00: SAFC(R) & Cherokee Pharmaceuticals(TM) Pool Expertise and Resources With Strategic Partnership For U.S. Market

http://www.bioportfolio.com/news/SAFC%28R%29_%26amp%3B_Cherokee_Pharmaceuticals%28TM%29_Pool.html

07:00: Back to Normal: Surgery Improves Outcomes for Spine Patients

http://www.bioportfolio.com/news/Back_to_Normal%3A_Surgery_Improves_Outcomes_for.html

07:00: Easing the Pain of Father's Day Without Dad, Highmark Caring Place Helps Children Cope With the Death of a Parent

http://www.bioportfolio.com/news/Easing_the_Pain_of_Father%26apos%3Bs_Day_Without_Dad%2C.html

07:00: Burrill & Company and Khosla Ventures Invest in HCL CleanTech's Technology for Converting Cellulosic Materials into Low Cost Fermentable Sugars - Enabling Biofuels and Other Bioproducts

http://www.bioportfolio.com/news/Burrill_%26amp%3B_Company_and_Khosla_Ventures_Invest.html

07:00: SAFC Pharma's St. Louis HPAPI Conjugates Facility Receives SafeBridge Certification

http://www.bioportfolio.com/news/SAFC_Pharma%26apos%3Bs_St._Louis_HPAPI_Conjugates.html

07:00: Healthy Gums and a Healthy Heart: The Perio-Cardio Connection

http://www.bioportfolio.com/news/Healthy_Gums_and_a_Healthy_Heart%3A_The.html

07:00: Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting

http://www.bioportfolio.com/news/Prometheus_Presents_Proprietary_Oncology.html

07:00: AEterna Zentaris Presents Data Supporting Evaluation of AEZS-108 in Prostate Cancer at ASCO Meeting

http://www.bioportfolio.com/news/AEterna_Zentaris_Presents_Data_Supporting.html

07:00: vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque

http://www.bioportfolio.com/news/vProtect%28TM%29_Luminal_Shield_Stabilizes_Vulnerable.html

07:00: Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel

http://www.bioportfolio.com/news/Micromet_Presents_Update_at_ASCO_2009_on_a_Phase.html

07:00: Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients

http://www.bioportfolio.com/news/Entremed_Presents_Results_of_ENMD-2076_Phase_1.html

07:00: Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

http://www.bioportfolio.com/news/Trubion_Announces_Positive_Data_From_a_Phase_1_%2F.html

07:00: MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa

http://www.bioportfolio.com/news/MDS_Announces_Strategy_to_Focus_MDS_Pharma.html

06:54: Heart Disease Treatment Breakthrough

http://www.bioportfolio.com/news/Heart_Disease_Treatment.html

06:30: TNFerade(TM) Phase III Data Presented at ASCO

http://www.bioportfolio.com/news/TNFerade%28TM%29_Phase_III_Data_Presented_at.html

06:00: Aurora St. Luke's Dedicates Rooftop Healing Garden and Conservatory

http://www.bioportfolio.com/news/Aurora_St._Luke%26apos%3Bs_Dedicates_Rooftop_Healing.html

06:00: Push-ups 'I've got a Secret'

http://www.bioportfolio.com/news/Push-ups_%26apos%3BI%26apos%3Bve_got_a.html

05:56: AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis

http://www.bioportfolio.com/news/AIMSPRO_is_Awarded_TGA_Orphan_Status_for_the.html

05:30: Kay Renz PR to Workout Publicity Routine for Adriana Martin, Founder of Fit Mom For Life

http://www.bioportfolio.com/news/Kay_Renz_PR_to_Workout_Publicity_Routine_for.html

05:30: Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy

http://www.bioportfolio.com/news/Cephalon_Announces_the_Availability_of_NUVIGIL.html

05:15: Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables

http://www.bioportfolio.com/news/Results_and_Additional_Analyses_From_Study_Show.html

04:00: Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectrometer

http://www.bioportfolio.com/news/Waters_Introduces_New_SYNAPT_G2_with_Greater.html

03:00: Mrs. Lily Safra, President of the Edmond J. Safra Foundation, to Announce Major New Medical Research Initiative During Israel Visit

http://www.bioportfolio.com/news/Mrs._Lily_Safra%2C_President_of_the_Edmond_J._Safra.html

03:00: PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer

http://www.bioportfolio.com/news/PROSTVAC%28TM%29_Data_Presented_at_the_ASCO_Meeting.html

01:15: FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing

http://www.bioportfolio.com/news/FDA_Approves_Reclast%28R%29_to_Prevent_Osteoporosis.html

00:01: IT Budgets of Healthcare Organizations in Asia Pacific Region Expected to Grow, Regardless of the Economic Slowdown, says Frost & Sullivan

http://www.bioportfolio.com/news/IT_Budgets_of_Healthcare_Organizations_in_Asia.html

00:01: Kaiser Family Foundation Launches New Non-Profit Health Policy News Service

http://www.bioportfolio.com/news/Kaiser_Family_Foundation_Launches_New_Non-Profit.html

00:01: Mylan Announces Successful Matrix Delisting Offer

http://www.bioportfolio.com/news/Mylan_Announces_Successful_Matrix_Delisting.html

00:01: CBay Announces the MTSO Partnership Program to Drive Digital Health Record Adoption

http://www.bioportfolio.com/news/CBay_Announces_the_MTSO_Partnership_Program_to.html

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.